Latest posts

  • NYT: “A.I. Turns Its Artistry to Creating New Human Proteins”

    NYT: “A.I. Turns Its Artistry to Creating New Human Proteins”

    The New York TImes has reported on how, Inspired by digital image generators like DALL-E, our scientists are building artificial intelligences that can fight cancer, flu and COVID-19.

  • Establishing our first international translational research project

    Establishing our first international translational research project

    From our partners at the BioInnovation Institute: BioInnovation Institute (BII), an international enterprise foundation with a non-profit objective incubating and accelerating world-class life science research, announces today that it has accepted a new project into its Bio Studio program. Based on recent breakthroughs in Artificial Intelligence (AI) and protein design,…

  • David Baker to present at the NIH Director’s Lecture Series

    David Baker to present at the NIH Director’s Lecture Series

    David Baker presented at the NIH Director’s Wednesday Afternoon Lecture Series on December 14, 2022. From the National Institutes of Health: The NIH Director’s Wednesday Afternoon Lecture Series, colloquially known as WALS, is the highest-profile lecture program at the NIH. Traditionally, lectures have occurred on most Wednesdays from September through…

  • A diffusion model for protein design

    A diffusion model for protein design

    Update (July 2023): Our manuscript on the development of RFdiffusion has been published in Nature. A team led by scientists from the Baker Lab has created a powerful new way of designing proteins that combines structure prediction networks and generative diffusion models. The team demonstrated extremely high computational success using…

  • ProteinMPNN excels at creating new proteins

    ProteinMPNN excels at creating new proteins

    Over the past two years, machine learning has revolutionized protein structure prediction. Now, three papers in Science describe a similar revolution in protein design. In the new papers, scientists in the Baker lab show that machine learning can be used to create proteins much more accurately and quickly than previously…

  • Design of membrane-traversing peptides leads to new spinout

    Design of membrane-traversing peptides leads to new spinout

    Researchers at the Institute for Protein Design have discovered how to create peptides that slip through membranes and enter cells. This drug design breakthrough may lead to new medications for a wide variety of health disorders, including cancer, infection, and inflammation. This research appears in the journal Cell [PDF]. “This…

  • Annual Report 2022

    Annual Report 2022

    Protein design reached two major milestones this year: Our Institute succeeded in producing its first fully-approved medicine, and our spinout companies have together raised over one billion dollars in capital. We are pleased to present this overview of the progress made at the Institute for Protein Design during the past…

  • Biosensor startup Monod secures $25M seed financing

    Biosensor startup Monod secures $25M seed financing

    Monod Bio, a life sciences company developing custom diagnostic biosensors that emit light to detect specific biomolecules of interest, today announced it has raised a $25M seed financing round. The round was led by Matrix Capital, with participation from the Global Health Investment Corporation, Cercano Management, The Washington Research Foundation,…

  • Celebrating our 10-year anniversary

    Celebrating our 10-year anniversary

      This week we celebrated the 10-year anniversary of the Institute for Protein Design. Current members, advisors, supporters, and old friends all came together on campus to share memories and forge new friendships. It was a night to remember. A lot has changed in the past decade. At our founding,…

  • Training A.I. to generate medicines and vaccines

    Training A.I. to generate medicines and vaccines

    Today we report in Science [PDF] the development of artificial intelligence software that can create proteins that may be useful as vaccines, cancer treatments, or even tools for pulling carbon pollution out of the air. This project was led by Jue Wang, Doug Tischer, and Joseph L. Watson, who are…